We are live on ! Find out more
SFCM

Seven Fleet Capital Management Portfolio holdings

AUM $318M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$318M
AUM Growth
+$170M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
144
New
Increased
Reduced
Closed

Top Buys

1 +$6.2M
2 +$5.04M
3 +$4.51M
4
TNGX icon
Tango Therapeutics
TNGX
+$3.99M
5
TYRA icon
Tyra Biosciences
TYRA
+$3.76M

Top Sells

1 +$81.6M
2 +$5.27M
3 +$3.01M
4
COGT icon
Cogent Biosciences
COGT
+$2.39M
5
BLTE
Belite Bio
BLTE
+$1.47M

Sector Composition

1 Healthcare 55.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNGX icon
1
Tango Therapeutics
TNGX
$5.12B
$10.5M 3.3%
502,012
+286,840
RVMD icon
2
Revolution Medicines
RVMD
$38.7B
$7.86M 2.47%
80,792
+14,992
TYRA icon
3
Tyra Biosciences
TYRA
$1.9B
$7.49M 2.35%
195,685
+116,125
LQDA icon
4
Liquidia Corp
LQDA
$6.95B
$7.09M 2.23%
187,876
+96,609
AGIO icon
5
Agios Pharmaceuticals
AGIO
$2.25B
$7.09M 2.23%
209,547
+177,809
IPSC icon
6
Century Therapeutics
IPSC
$418M
$6.66M 2.09%
+2,947,826
ELVN icon
7
Enliven Therapeutics
ELVN
$3.58B
$6.43M 2.02%
164,030
+64,077
PCVX icon
8
Vaxcyte
PCVX
$8.16B
$6.3M 1.98%
108,450
+83,085
COGT icon
9
Cogent Biosciences
COGT
$6.51B
$5.75M 1.81%
149,399
-64,700
CGON icon
10
CG Oncology
CGON
$6.35B
$5.13M 1.61%
75,758
-1,439,393
PHVS icon
11
Pharvaris
PHVS
$2.38B
$4.88M 1.53%
172,731
+117,389
ABVX
12
Abivax
ABVX
$7.78B
$4.79M 1.51%
43,052
+29,553
DNTH icon
13
Dianthus Therapeutics
DNTH
$5.21B
$4.55M 1.43%
54,258
+39,607
CYTK icon
14
Cytokinetics
CYTK
$11.2B
$4.04M 1.27%
61,269
+50,934
SLNO
15
DELISTED
Soleno Therapeutics
SLNO
$3.88M 1.22%
115,770
-14,309
ERAS icon
16
Erasca
ERAS
$4.98B
$3.6M 1.13%
+222,468
ROIV icon
17
Roivant Sciences
ROIV
$24.5B
$3.55M 1.12%
+128,168
AVTX icon
18
Avalo Therapeutics
AVTX
$957M
$3.19M 1%
213,819
+150,476
EPRX
19
Eupraxia Pharmaceuticals
EPRX
$431M
$3.14M 0.99%
+433,515
IDYA icon
20
IDEAYA Biosciences
IDYA
$3.54B
$2.87M 0.9%
+86,283
TSHA icon
21
Taysha Gene Therapies
TSHA
$1.82B
$2.8M 0.88%
625,708
+458,485
ASND icon
22
Ascendis Pharma A/S
ASND
$17.1B
$2.79M 0.88%
12,179
+6,509
CMPX icon
23
Compass Therapeutics
CMPX
$375M
$2.73M 0.86%
516,972
-51,775
DMRA
24
Damora Therapeutics
DMRA
$1.56B
$2.62M 0.82%
+101,248
KALV
25
DELISTED
KalVista Pharmaceuticals
KALV
$2.59M 0.81%
128,487
+80,075